Personalized Heart Prevention Study
Part of Heart & circulation clinical trials.
This study tests new, personalized ways to prevent heart disease in people with metabolic syndrome. It aims to see if custom approaches can lower your risk of heart attacks and strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 to 69 years old.
- Your estimated heart attack or stroke risk over the next 10 years is between 2.5% and 10% (SCORE2).
- You have metabolic syndrome (at least 3 of these: large waist, high triglycerides, low HDL, high blood pressure, or high blood sugar).
- You do not have diabetes, familial hypercholesterolemia, or a history of heart attack/stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a tailored prevention plan can improve outcomes and help with costs for people at high risk of coronary heart disease. You may join if you’ve had recent heart events or scans show significant blockage, and if you can follow the visit and app requirements.
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
This trial looks at an individualized prevention approach for people who are at higher risk of heart and blood vessel problems. It aims to help lower future cardiovascular risk before heart disease develops.
This trial compares two ways to prevent heart attacks and strokes: one uses a special heart CT scan to guide care, the other uses standard risk factors like blood pressure and cholesterol. You may be eligible if you are older (men over 55, women over 65) and have diabetes, prediabetes, or metabolic syndrome.
This study follows people to understand heart disease risk by combining a heart risk score with genetic risk (polygenic risk). It may help improve how doctors identify who is at higher risk and could guide prevention planning.
This trial uses a polygenic risk score to see if knowing your genetic risk for coronary artery disease can help prevent a first heart attack. If you have an intermediate 10-year risk and no prior heart events, you may be eligible.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.